C12N2750/14011 - CPC Classification

ssDNA viruses; Details Parvoviridae

• C12N2750/14021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 9
• C12N2750/14022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 12
• C12N2750/14023 » Virus like particles [VLP] 11
• C12N2750/14031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 2
• C12N2750/14032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 19
• C12N2750/14033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 8
• C12N2750/14034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 32
• C12N2750/14041 » Use of virus, viral particle or viral elements as a vector 12
• C12N2750/14051 » Methods of production or purification of viral material 15
• C12N2750/14061 » Methods of inactivation or attenuation 6
• C12N2750/14071 » Demonstrated in vivo effect 34
• C12N2750/14088 » For redistribution 0
• C12N2750/14111 » Dependovirus, e.g. adenoassociated viruses 38
• C12N2750/14211 » Erythrovirus, e.g. B19 virus 1
• C12N2750/14311 » Parvovirus, e.g. minute virus of mice 4

Recent Application in this class: